Multiple eccrine hidrocystomas: a new therapeutic option with botulinum toxin.
BACKGROUND
Multiple eccrine hidrocystomas are benign cystic lesions that are associated with a chronic course and seasonal variability. Even though in the literature it is presented as a very infrequent pathology, we think this is more a lack of knowledge of the existence of said pathology and the fact that patients confuse it with comedo.


OBJECTIVE
To treat multiple eccrine hidrocystomas of the face.


RESULTS
We present a case of multiple eccrine hidrocystomas of the face in a cook man. Hidrocystoma is a benign cystic tumor of the sweat glands eccrine or apocrine. Multiple eccrine hidrocystomas are benign cystic lesions that are associated with a chronic course and seasonal variability. They appear like multiple shining small papule. Although a solitary eccrine hidrocystoma can be treated easily with surgical excision, the elimination of multiple lesions is problematic because of their number and location.


CONCLUSIONS
The benefits of BTX-A treatment for multiple eccrine hidrocystomas include ease of application, no risk of scarring, and a good postoperative course. Because of the blockage produced by BTX-A on cholinergic terminals of the parasympathetic system that governs sweat glands secretion, it is suggested that periodic doses of BTX-A are injected in the superficial epidermis in order to treat multiple eccrine hidrocystomas.
Blugerman
Guillermo
G
B&S Centro de Excelencia en Cirugía Plástica, Buenos Aires, Argentina. info@clinicabys.com
Schavelzon
Diego
D
D'Angelo
Silvana
S
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005145:Face; D018251:Hidrocystoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D013544:Sweat Gland Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A